VJ

Vaishaliben Jayeshbhai Patel

Active Director Director DIN 09581861
DIN 09581861 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vaishaliben Jayeshbhai Patel

Data last updated:

Vaishaliben Jayeshbhai Patel is a Director at Gunatit Pharma Private Limited (since 2022). The company operates in Pharma.

DIN 09581861
Primary Designation Director
Industry Pharma
First Appointment 22 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gunatit Pharma Private Limited U24290GJ2022PTC131312
Director22 Apr 20222022Active

Board colleagues of Vaishaliben Jayeshbhai Patel

NameDINCompanyDesignation
Mittal Mitesh Patel09581862Gunatit Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gunatit Pharma Private Limited
Premium access

Shareholding and investment profile for Vaishaliben Jayeshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaishaliben Jayeshbhai Patel

Vaishaliben Jayeshbhai Patel currently holds 1 directorship: Gunatit Pharma Private Limited (Director, since 22 Apr 2022).

Vaishaliben Jayeshbhai Patel was first appointed on 22 Apr 2022 as Director at Gunatit Pharma Private Limited.

The current boards of Vaishaliben Jayeshbhai Patel's companies include Mittal Mitesh Patel (Gunatit Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available